Market Exclusive

HCA Holdings Inc (NYSE:HCA) Acquires Satilla Regional Medical Center In Waycross

HCA Holdings Inc (NYSE:HCA), has confirmed its purchase of a 231-bed hospital in Waycross. The institution, which already owns 10 hospitals in Houston and a dozen surgery centers, will be adding Satilla Regional Medical Center to its list of acquisitions. The Nashville, Tennessee-based Corporation is regarded as one of the nation’s largest hospital owner-operators given its strong presence in the market.

In line with its operations, HCA intends to adopt a new name for the new acquisition from Satilla Regional Medical Center to Memorial Satilla Health. The company explains that the change of name is in an effort to ensure continued delivery of care in Waycross.

HCA’s achievement is no mean feat

The corporation is the largest for-profit health care provider in the U.S. Over the years, it has showcased its commitment to being a reliable healthcare leader. Concurring to this, Owen Herrin, the new board chairman outlines, “HCA is that partner – a healthcare leader that understands and is committed to high-quality, community-based hospitals.”

He points out the excitement of having found a partner with the same culture who will continue to empower them in their continued healthcare activities across the country. Besides, the Waycross team has made a record of delivering extraordinary service to the community and the immediate neighbors.

The Nashville-based HCA has an eye on other deals

HCA says its acquisition will be integrated into the company’s South Atlantic Division, which operates 12 hospitals and is based in Charleston. Hugh Tappan, the division’s president acknowledges their dedication in collaborating with larger HCA family in the provision of the right services.

The company will be buying another three Houston hospitals. One of the deals, which is expected to close in the third quarter involves Dallas-based Tenet Healthcare Corp (NYSE:THC) while the other is from Franklin.

Clearly, HCA has been doing well given its reporting of $41.4 billion in revenue in 2016. This was an increase from the $39.6 billion recorded in the previous year. In the meantime, HCA’s stock was trading at $82.85 a fall of $1.89 or 2.23%.

Exit mobile version